[해외논문]Diagnostic Testing for Rett Syndrome by DHPLC and Direct Sequencing Analysis of the MECP2 Gene: Identification of Several Novel Mutations and Polymorphisms원문보기
Rett syndrome (RTT) is an X-linked dominant neurodevelopmental disorder affecting 1/10,000-15,000 girls. The disease-causing gene was identified as MECP2 on chromosome Xq28, and mutations have been found in ~80% of patients diagnosed with RTT. Numerous mutations have been identified in de novo and r...
Rett syndrome (RTT) is an X-linked dominant neurodevelopmental disorder affecting 1/10,000-15,000 girls. The disease-causing gene was identified as MECP2 on chromosome Xq28, and mutations have been found in ~80% of patients diagnosed with RTT. Numerous mutations have been identified in de novo and rare familial cases, and they occur primarily in the methyl-CpG-binding and transcriptional-repression domains of MeCP2. Our first diagnostic strategy used bidirectional sequencing of the entire MECP2 coding region. Subsequently, we implemented a two-tiered strategy that used denaturing high-performance liquid chromatography (DHPLC) for initial screening of nucleotide variants, followed by confirmatory sequencing analysis. If a definite mutation was not identified, then the entire MECP2 coding region was sequenced, to reduce the risk of false negatives. Collectively, we tested 228 unrelated female patients with a diagnosis of possible (209) or classic (19) RTT and found MECP2 mutations in 83 (40%) of 209 and 16 (84%) of 19 of the patients, respectively. Thirty-two different mutations were identified (8 missense, 9 nonsense, 1 splice site, and 14 frameshifts), of which 12 are novel and 9 recurrent in unrelated patients. Seven unclassified variants and eight polymorphisms were detected in 228 probands. Interestingly, we found that T203M, previously reported as a missense mutation in an autistic patient, is actually a benign polymorphism, according to parental analysis performed in a second case identified in this study. These findings highlight the complexities of missense variant interpretation and emphasize the importance of parental DNA analysis for establishing an etiologic relation between a possible mutation and disease. Overall, we found a 98.8% concordance rate between DHPLC and sequence analyses. One mutation initially missed by the DHPLC screening was identified by sequencing. Modified conditions subsequently enabled its detection, underscoring the need for multiple optimized conditions for DHPLC analysis. We conclude that this two-tiered approach provides a sensitive, robust, and efficient strategy for RTT molecular diagnosis.
Rett syndrome (RTT) is an X-linked dominant neurodevelopmental disorder affecting 1/10,000-15,000 girls. The disease-causing gene was identified as MECP2 on chromosome Xq28, and mutations have been found in ~80% of patients diagnosed with RTT. Numerous mutations have been identified in de novo and rare familial cases, and they occur primarily in the methyl-CpG-binding and transcriptional-repression domains of MeCP2. Our first diagnostic strategy used bidirectional sequencing of the entire MECP2 coding region. Subsequently, we implemented a two-tiered strategy that used denaturing high-performance liquid chromatography (DHPLC) for initial screening of nucleotide variants, followed by confirmatory sequencing analysis. If a definite mutation was not identified, then the entire MECP2 coding region was sequenced, to reduce the risk of false negatives. Collectively, we tested 228 unrelated female patients with a diagnosis of possible (209) or classic (19) RTT and found MECP2 mutations in 83 (40%) of 209 and 16 (84%) of 19 of the patients, respectively. Thirty-two different mutations were identified (8 missense, 9 nonsense, 1 splice site, and 14 frameshifts), of which 12 are novel and 9 recurrent in unrelated patients. Seven unclassified variants and eight polymorphisms were detected in 228 probands. Interestingly, we found that T203M, previously reported as a missense mutation in an autistic patient, is actually a benign polymorphism, according to parental analysis performed in a second case identified in this study. These findings highlight the complexities of missense variant interpretation and emphasize the importance of parental DNA analysis for establishing an etiologic relation between a possible mutation and disease. Overall, we found a 98.8% concordance rate between DHPLC and sequence analyses. One mutation initially missed by the DHPLC screening was identified by sequencing. Modified conditions subsequently enabled its detection, underscoring the need for multiple optimized conditions for DHPLC analysis. We conclude that this two-tiered approach provides a sensitive, robust, and efficient strategy for RTT molecular diagnosis.
참고문헌 (22)
J Hum Genet Amano 45 231 2000 10.1007/s100380070032 Mutational analysis of the MECP2 gene in Japanese patients with Rett syndrome
Ann Neurol Amir 47 670 2000 10.1002/1531-8249(200005)47:5<670::AID-ANA20>3.0.CO;2-F Influence of mutation type and X chromosome inactivation on Rett syndrome phenotypes
Hum Mol Genet Cheadle 9 1119 2000 10.1093/hmg/9.7.1119 Long-read sequence analysis of the MECP2 gene in Rett syndrome patients: correlation of disease severity with mutation type and location
Acta Paediatr Scand Hagberg 74 405 1985 10.1111/j.1651-2227.1985.tb10993.x Rett’s syndrome: prevalence and impact on progressive severe mental retardation in girls
Ann Neurol Hagberg 14 471 1983 10.1002/ana.410140412 A progressive syndrome of autism, dementia, ataxia and loss of purposeful hand use in girls: Rett’s syndrome: report of 35 cases
Hum Mutat Kim 15 382 2000 10.1002/(SICI)1098-1004(200004)15:4<382::AID-HUMU16>3.0.CO;2-8 Novel de novo nonsense mutation of MECP2 in a patient with Rett syndrome
Nucleic Acids Res Liu 26 1396 1998 10.1093/nar/26.6.1396 Denaturing high-performance liquid chromatography (DHPLC) used in the detection of germline and somatic mutations
Genomics O’Donovan 52 44 1998 10.1006/geno.1998.5411 Blind analysis of denaturing high-performance liquid chromatography as a tool for mutation detection
Am J Hum Genet Oefner 57 A266 1995 Comparative DNA sequencing by denaturing high-performance liquid chromatography (DHPLC)
Oefner 7.10.1 1998 Current protocols in human genetics, Suppl 19 DNA mutation detection using denaturing high-performance liquid chromatography (DHPLC)
FEBS Lett Orrico 24106 1 2000 MECP2 mutation in male patients with non-specific X-linked mental retardation
Mamm Genome Reichwald 11 182 2000 10.1007/s003350010035 Comparative sequence analysis of the MECP2-locus in human and mouse reveals new transcribed regions
Wien Med Wochenschr Rett 116 723 1966 Uber ein eigenartiges hirnatrophisches syndrom bei hyperamonaemie im kindesalter
Am J Hum Genet Schanen 63 267 1998 10.1086/301932 A severely affected male born into a Rett syndrome kindred supports X-linked inheritance and allows extension of the exclusion map
AI-Helper
※ AI-Helper는 부적절한 답변을 할 수 있습니다.